Inhibrx Biosciences INBX
NASDAQ INBX
$104.70 +2.99 (+2.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Inhibrx Biosciences (INBX) Assets (2023 - 2026)

Updated

Inhibrx Biosciences' Assets came in at $154.22 million for Q2 2026, down 27.3% from $212.12 million a year earlier.

Analysis

Inhibrx Biosciences (INBX) Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Inhibrx Biosciences' Assets was $146.48 million, down 19.0% from FY2024.

  • Going back by year, Assets was $180.77 million in FY2024 (-41.3%) and $307.89 million in FY2023.
  • The five-year range for quarterly Assets is $146.48 million (Q4 2025) to $307.89 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Inhibrx Biosciences 1.50 Bn 1.50 Bn - 154.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 154.22 Mn
Dec 31, 2025 146.48 Mn
Sep 30, 2025 177.47 Mn
Jun 30, 2025 212.12 Mn
Mar 31, 2025 242.64 Mn
Dec 31, 2024 180.77 Mn
Sep 30, 2024 222.56 Mn
Jun 30, 2024 258.42 Mn
Dec 31, 2023 307.89 Mn
API Access

Inhibrx Biosciences Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=INBX&period=max&api_key=YOUR_API_KEY